Skip to main content

Table 6 Assessment of the OX-NDA against feasibility criteria for use of an early child developmental assessment in a low- and middle-income setting

From: Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children

Feasibility Criteria

Does OX-NDA fulfil the criteria?

Additional details

World Bank Toolkit for Examining ECD1

 Psychometrically adequate, valid and reliable

Yes

ICCs 0·63 and 0·68 (p < 0·001) between BSID-III and OX-NDA for cognition, and total score domains; and motor composite; ICC 0.30 (p < 0.04) for language composite. Internal consistency satisfactory. Sensitivity in predicting BSID-III composite scores < 85 (moderate delay) was 76, 73, and 43% for the OX-NDA cognition, motor and language domains at cut-off scores of <=60, 73, and 60 respectively. Specificity in predicting BSID-III composite scores < 85 (moderate delay) was 75, 80, and 33% for the OX-NDA cognition, motor, and language domains at cut-off scores of <=60, 73, and 60 respectively. Inter-rater reliability and test-rest reliability was k = 0.80-0.96, 95% CI: 0.78-0.97 and k = 0.85-0.94, 95% CI: 0.80-0.95 across all domains.

 Balanced in terms of number of items at the lower end to avoid children with low scores

Yes

Age range of items extend to 6 months

 Enjoyable for children to take (e.g. interactive, colourful materials)

Yes

 

 Relatively easy to adapt to various cultures

Yes

Adapted via cultural customisation session during training and currently in use in Brazil, India, and Grenada

 Easy to use in low-resource settings, e.g. not requiring much material

Yes

Cost of kit GBP 100.0; no fee per use; manuals and forms available upon request, mobile phone/tablet based OX-NDA E-form available.

 Not too difficult to obtain or too expensive

Yes

See above

 Able to be used in a wide age range

No

Moderately narrow age range (10 to 14 months)

Fischer et al’s feasibility criteria for use of developmental screening tools at primary healthcare level in low-middle income settings2

 Results understood by health workers

Yes

Cut-offs for moderate-to-severe delay

 Reliable

Yes

High, inter-rater reliability and test-rest reliability of k = 0.80-0.96, 95% CI: 0.78-0.97 and k = 0.85-0.94, 95% CI: 0.80-0.95 across all subscales.

 Valid

Yes

See above

 Acceptable to caregivers

Yes

 

 Provides information that is relevant to primary care providers

Yes

Cut-offs

 Information that can be used for referrals of early intervention

Yes

Cut-offs

 Information that is useful for anticipatory guidance

Unknown

 

 Results understood by caregivers

Yes

 

 Staff members have the expertise to answer questions

Yes

Session on maternal questions and responses included in training package.

 Access to application

Yes

Manuals, paper forms and E-form available upon request.

 Training involved

Yes

Time taken to train assessors in the OX-NDA: 1 day for ≤3 assessors, 2 days for 3-5 assessors, 3 days for 5-10 assessors

 How long it takes to administer the tool

Yes

15-25 minutes

 Cover multiple areas of child development

Yes

Cognition, language, motor skills, and behaviour (positive and negative)

 Cost of the tool

Yes

Cost of kit GBP100.0; no fee per use; mobile phone/tablet based OX-NDA E-form available.

 Minimal adaptation needed

Yes

Sessions on cultural customisation and translation included in training

 Educational level of staff members

Yes

Primary education; non-specialist personnel

 How many staff members to administer the tool

Yes

1

 Local norms available

Yes

Cut-offs based on Brazilian sample. Research to develop international norms on-going.

 Space

Yes

Minimal space for storage of kit and forms. Mobile phone/tablet based OX-NDA E-form available. Home-based assessments possible.

Boggs et al’s rating of early child development outcome measurement tools for routine health programme use3

 Validity

Rating: 2

Validity somewhat below widely accepted threshold (0.5 to 0.7) against another performance-based tool e.g. BSID-III

 Reliability

Rating: 3

High, inter-rater reliability and test-rest reliability of k = 0.80-0.96, 95% CI: 0.78-0.97 and k = 0.85-0.94, 95% CI: 0.80-0.95 across all subscales.

 Cultural Adaptability

Rating: 3

Easy modification of items, materials and procedures

 Accessibility

Rating: 2

Tool administration, scoring and interpretation, all available online, but some intellectual property or other restrictions.

Minimal cost to tool <US$ 10 per child

App (mobile phone/tablet based OX-NDA E-form) available

 Training

Rating: 2

Moderate (> 1 hour to < 1 day), requires standardization and training on direct assessment of children’s abilities, no certification requirement.

 Administration time

Rating: 2

< 15 to 20 minutes, minimum to moderate scoring.

 Geographical uptake

Rating: 3

Used in at least three continents (Asia, Europe, South America)

 Clinical relevance and utility

Rating: 2

Sensitivity in predicting BSID-III composite scores < 85 (moderate delay) was 76, 73, and 43% for the OX-NDA cognition, motor and language domains at cut-off scores of <=60, 73 and 60 respectively. Specificity in predicting BSID-III composite scores < 85 (moderate delay) was 75, 80, and 33% for the OX-NDA cognition, motor and language domains at cut-off scores of <=60, 73, and 60 respectively.

Further research to develop international norms, and contextually appropriate referral pathways underway.

  1. ECD Early child development
  2. OX-NDA The Oxford Neurodevelopment Assessment
  3. BSID-III The Bayley Scales of Infant Development III edition
  4. ICC interclass correlation coefficients
  5. CI Confidence intervals
  6. k Cohen’s kappa coefficient
  7. 1Fernald LCH, Kariger P, Engle P, et al. Examining Early Child Development in Low-Income Countries: A Toolkit for the Assessment of Children in the First 5 Years of Life. Washington DC: The World Bank, 2009
  8. 2Fischer VJ, Morris J, Martines J. Developmental screening tools: feasibility of use at primary healthcare level in low-and middle-income settings. Journal of health, population, and nutrition 2014;32(2):314
  9. 3Boggs D, Milner KM, Chandna J, et al. Rating early child development outcome measurement tools for routine health programme use. Archives of disease in childhood 2019;104 (Suppl 1):S22-S33